Prognostic factors for remission in early rheumatoid arthritis:: a multiparameter prospective study

被引:98
作者
Gossec, L
Dougados, M
Goupille, P
Cantagrel, A
Sibilia, J
Meyer, O
Sany, J
Daurès, JP
Combe, B
机构
[1] Univ Paris 05, Cochin Hosp, Dept Rheumatol B, Paris, France
[2] CHU Tours, Tours, France
[3] CHU Rangueil, F-31054 Toulouse, France
[4] CHU Strasbourg, F-67000 Strasbourg, France
[5] CHU Bichat, Paris, France
[6] CHU Montpellier, Serv Immunorhumatol, Montpellier, France
[7] INSERM, U454, Montpellier, France
[8] Inst Univ Rech Clin, Montpellier, France
关键词
D O I
10.1136/ard.2003.010611
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To determine prognostic factors for remission in early rheumatoid arthritis. Methods: 191 patients with rheumatoid arthritis whose disease duration was less than one year were followed up prospectively for five years. Remission, defined by a disease activity score (DAS) of <1.6, was used as the outcome measure. Baseline clinical, laboratory, genetic, and radiographic data ( with radiographic scores determined by Sharp's method, modified by van der Heijde) were obtained. Results: 48 patients (25.1%) fulfilled the remission criteria at the three year follow up visit, and 30 (15.7%) at three and five years. On univariate analysis by Fisher's exact test, remission at three years and persistent remission at five years were closely correlated with baseline DAS values, C reactive protein level, Ritchie score, health assessment questionnaire score, duration of morning stiffness, and to a lesser extent baseline total radiological scores and rheumatoid factor negativity. No significant correlation was found with sex, age, extra-articular manifestations, erythrocyte sedimentation rate, anti-cyclic citrullinated protein antibodies, anti-keratin antibodies, anti-HSP 90, anticalpastatin antibodies, antinuclear antibodies, or HLA-DRB1* genotypes. Logistic regression analysis showed that the baseline independent variables predictive of remission were low DAS, Ritchie score, morning stiffness duration, and total radiographic score. Conclusions: Baseline prognostic factors for remission in early rheumatoid arthritis were mainly clinical markers of disease activity and radiological scores.
引用
收藏
页码:675 / 680
页数:6
相关论文
共 39 条
[1]  
ALARCON GS, 1987, J RHEUMATOL, V14, P93
[2]   THE AMERICAN-RHEUMATISM-ASSOCIATION 1987 REVISED CRITERIA FOR THE CLASSIFICATION OF RHEUMATOID-ARTHRITIS [J].
ARNETT, FC ;
EDWORTHY, SM ;
BLOCH, DA ;
MCSHANE, DJ ;
FRIES, JF ;
COOPER, NS ;
HEALEY, LA ;
KAPLAN, SR ;
LIANG, MH ;
LUTHRA, HS ;
MEDSGER, TA ;
MITCHELL, DM ;
NEUSTADT, DH ;
PINALS, RS ;
SCHALLER, JG ;
SHARP, JT ;
WILDER, RL ;
HUNDER, GG .
ARTHRITIS AND RHEUMATISM, 1988, 31 (03) :315-324
[3]  
Brown AK, 2002, ARTHRITIS RHEUM-US, V46, pS331
[4]  
COMBE B, 1995, BRIT J RHEUMATOL, V34, P529
[5]  
Combe B, 2001, ARTHRITIS RHEUM, V44, P1736, DOI 10.1002/1529-0131(200108)44:8<1736::AID-ART308>3.0.CO
[6]  
2-I
[7]  
DIXON WJ, 1988, BMDP STAT SOFTWARE M, V2
[8]   Combination therapy in early rheumatoid arthritis: a randomised, controlled, double blind 52 week clinical trial of sulphasalazine and methotrexate compared with the single components [J].
Dougados, M ;
Combe, B ;
Cantagrel, A ;
Goupille, P ;
Olive, P ;
Schattenkirchner, M ;
Meussr, S ;
Paimela, L ;
Rau, R ;
Zeidler, H ;
Leirisalo-Repo, M ;
Peldan, K .
ANNALS OF THE RHEUMATIC DISEASES, 1999, 58 (04) :220-225
[9]  
Eberhardt K, 1998, BRIT J RHEUMATOL, V37, P1324
[10]   EARLY RHEUMATOID-ARTHRITIS - ONSET, COURSE, AND OUTCOME OVER 2 YEARS [J].
EBERHARDT, KB ;
RYDGREN, LC ;
PETTERSSON, H ;
WOLLHEIM, FA .
RHEUMATOLOGY INTERNATIONAL, 1990, 10 (04) :135-142